FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Source: FactSetДata are provided 'as is' for informational purposes only and are not intended for trading purposes. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Sources: FactSet, Tullett PrebonД¬ommodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Sources: FactSet, Tullett PrebonД¬urrencies: Currency quotes are updated in real-time. Sources: FactSet, Dow JonesД«onds: Bond quotes are updated in real-time. Sources: FactSet, Dow JonesД®TF Movers: Includes ETFs & ETNs with volume of at least 50,000. Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Overview page represent trading in all U.S. Indexes: Index quotes may be real-time or delayed as per exchange requirements refer to time stamps for information on any delays. Copyright 2019В© FactSet Research Systems Inc. Fundamental company data and analyst estimates provided by FactSet. International stock quotes are delayed as per exchange requirements. stock quotes reflect trades reported through Nasdaq only comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

On the date of publication, Samuel OвЂ™Brient did not have (either directly or indirectly) any positions in the securities mentioned in this article. Wall Street will be watching carefully for the formerвЂ™s earnings report, but nothing so far indicates that it will be good news for the company or for investors. While Rite Aid has been struggling, its rival CVS (NYSE: CVS) has managed to raise its 2022 guidance. However, even the pandemic couldnвЂ™t help RAD come close to where it was trading in 2017. have declined, so has demand for preventative measures. WhatвЂ™s clear from Rite AidвЂ™s performance is that much of the companyвЂ™s recent success can be attributed to Covid-19-related products and services, specifically testing and vaccines. With so much at stake, thereвЂ™s little incentive for investors to stand by RAD. He added that, вЂњAt a number below $400mm, the equity arguably has no value as the company is not in a position to generate real returns to shareholders.вЂќДЇor investors, there is a lot riding on the upcoming report, particularly if the company is in danger of folding.

He stressed that вЂњRite Aid needs to generate between $400 million to $450 millionвЂќ in adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) if it wants to stay in business. In his issued note on RAD, Hill stressed the importance of the upcoming earnings. If it reports anything else, shares will likely continue falling and prove Hill correct. If Rite Aid reports positive earnings and surpasses Wall Street expectations, the stock may rebound. Investors should mark their calendars for a potential catalyst. The company reports Q4 earnings in exactly one week on April 14. HillвЂ™s predictions come at an important time for RAD stock.

Rad stock price